Literature DB >> 27859625

Loss of MicroRNA-489-3p promotes osteosarcoma metastasis by activating PAX3-MET pathway.

Qifei Liu1, Guochun Yang1, Yuying Qian2.   

Abstract

Osteosarcoma (OS) remains one deadly disease for many affected patients. MicroRNAs (miRNAs) are thought to have an important role in tumor metastasis by regulating diverse cellular pathways. Here, we describe the function and regulation network of miR-489-3p in osteosarcoma (OS) metastasis. MiR-489-3p expression was downregulated in OS cells especially in high metastatic potential cells and was also significantly decreased in metastatic lesions compared with their corresponding primary tumor samples. Both gain- and loss-of-function studies confirmed that miR-489-3p significantly suppressed OS cell invasion and metastasis both in vitro and in vivo. Mechanistically, paired box gene 3 (PAX3) was identified as a functional target of miR-489-3p in OS cells. MiR-489-3p inhibited OS metastasis by negatively regulating expression of PAX3. In addition, PAX3 expression was markedly higher in OS tissues than in adjacent non-cancerous tissues. Transwell assays and in vivo metastasis assays demonstrated that overexpression of PAX3 significantly promoted the invasiveness and pulmonary metastasis of OS cells. On the other hand, downregulation of PAX3 markedly reduced cell metastatic potential. Mechanistic investigations indicated that prometastasis function of PAX3 was mediated by upregulating downstream target MET tyrosine kinase receptor. In conclusion, our results reveal that miR-489-3p-PAX3-MET signaling is critical to OS metastasis. Targeting the pathway described here may open new therapeutic prospects to restrict the metastatic potential of OS.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  MET; MicroRNA-489-3p; PAX3; metastasis; osteosarcoma

Mesh:

Substances:

Year:  2016        PMID: 27859625     DOI: 10.1002/mc.22593

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  22 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  Expression profiling of microRNAs and isomiRs in conventional central chondrosarcoma.

Authors:  Antonina Parafioriti; Ingrid Cifola; Clarissa Gissi; Eva Pinatel; Laura Vilardo; Elisabetta Armiraglio; Andrea Di Bernardo; Primo Andrea Daolio; Armando Felsani; Igea D'Agnano; Anna Concetta Berardi
Journal:  Cell Death Discov       Date:  2020-06-10

3.  Autophagy, Cell Viability, and Chemoresistance Are Regulated By miR-489 in Breast Cancer.

Authors:  Mithil Soni; Yogin Patel; Eleni Markoutsa; Chunfa Jie; Shou Liu; Peisheng Xu; Hexin Chen
Journal:  Mol Cancer Res       Date:  2018-05-21       Impact factor: 5.852

4.  miR-489-3p inhibits TLR4/NF-κB signaling to prevent inflammation in psoriasis.

Authors:  Yujian Ye; Ping Wang; Fangmei Zhou
Journal:  Exp Ther Med       Date:  2021-05-11       Impact factor: 2.447

5.  miR‑328‑3p enhances the radiosensitivity of osteosarcoma and regulates apoptosis and cell viability via H2AX.

Authors:  Zhen Yang; Qing-De Wa; Chao Lu; Wei Pan; Zi-Μo Lu; Jun Ao
Journal:  Oncol Rep       Date:  2017-11-27       Impact factor: 3.906

6.  Biological analysis of cancer specific microRNAs on function modeling in osteosarcoma.

Authors:  Hao Wang; Min Tang; Liping Ou; Mengyi Hou; Tianyu Feng; Yu-E Huang; Yaqian Jin; Heng Zhang; Guowei Zuo
Journal:  Sci Rep       Date:  2017-07-14       Impact factor: 4.379

7.  Levobupivacaine Induces Ferroptosis by miR-489-3p/SLC7A11 Signaling in Gastric Cancer.

Authors:  Shun-Hong Mao; Chun-Hua Zhu; Yu Nie; Jian Yu; Lei Wang
Journal:  Front Pharmacol       Date:  2021-06-09       Impact factor: 5.810

8.  TRIM44, a crucial target of miR-410, functions as a potential oncogene in osteosarcoma.

Authors:  Heng Wang; Zi-Ling Fang; Gong-Hao Zhang; Xin Ma
Journal:  Onco Targets Ther       Date:  2018-06-21       Impact factor: 4.147

9.  DNA Methylation Influences miRNA Expression in Gonadotroph Pituitary Tumors.

Authors:  Joanna Boresowicz; Paulina Kober; Natalia Rusetska; Maria Maksymowicz; Agnieszka Paziewska; Michalina Dąbrowska; Natalia Zeber-Lubecka; Jacek Kunicki; Wiesław Bonicki; Jerzy Ostrowski; Janusz A Siedlecki; Mateusz Bujko
Journal:  Life (Basel)       Date:  2020-05-13

10.  Metformin Inhibits the Development of Hypopharyngeal Squamous Cell Carcinoma through Circ_0003214-Mediated MiR-489-3p-ADAM10 Pathway.

Authors:  Xiaoqiang Chen; Chen Li; Wei Chen; Shuchun Lin; Xuehan Yi; Qin Lin; Hao Xu; Desheng Wang
Journal:  J Oncol       Date:  2021-07-13       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.